HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bromocriptine, an ergot alkaloid, inhibits excitatory amino acid release mediated by glutamate transporter reversal.

Abstract
Bromocriptine, a dopamine D(2) receptor agonist, has widely been used for patients with Parkinson's disease. The aim of the present study was to investigate the effect of bromocriptine on glutamate transporter. Since the astroglial glutamate transporter GLT-1 (EAAT2) is the predominant isoform in the forebrain, we generated EAAT2-expressing human embryonic kidney cells and immortalized mouse astrocytes. In the present studies, we observed a GLT-1-immunoreactive band and significant Na(+)-dependent d-[(3)H] aspartate uptake. Furthermore, the glutamate transporter inhibitors, dl-threo-beta-benzyloxyaspartic acid (TBOA) and dihydrokainate (DHK), displayed a dose-dependent reduction of d-[(3)H] aspartate uptake in both types of cells. In contrast, cells exposed to either chemical anoxia or high KCl elicited a marked release of d-[(3)H] aspartate, and the release was inhibited by TBOA and DHK, implying the contribution of glutamate transporter reversal. Interestingly, we found that bromocriptine dose-dependently inhibits d-[(3)H] aspartate release elicited by chemical anoxia or high KCl, while no changes occurred in the uptake. The inhibitory action of bromocriptine was not affected by sulpiride, a dopamine D(2) receptor antagonist. On the other hand, bromocriptine had no effect on swelling-induced d-[(3)H] aspartate release, which is mediated by volume-regulated anion channels. In vivo studies revealed that bromocriptine suppresses the excessive elevation of glutamate levels in gerbils subjected to transient forebrain ischemia in a manner similar to DHK. Taken together, these results provide evidence that bromocriptine inhibits excitatory amino acid release via reversed operation of GLT-1 without altering forward transport.
AuthorsYasufumi Shirasaki, Masunobu Sugimura, Toshiyuki Sato
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 643 Issue 1 Pg. 48-57 (Sep 15 2010) ISSN: 1879-0712 [Electronic] Netherlands
PMID20599932 (Publication Type: Journal Article)
CopyrightCopyright (c) 2010 Elsevier B.V. All rights reserved.
Chemical References
  • Dopamine Agonists
  • Excitatory Amino Acid Antagonists
  • Excitatory Amino Acid Transporter 2
  • Excitatory Amino Acids
  • Bromocriptine
  • Glutamic Acid
Topics
  • Animals
  • Astrocytes (drug effects, metabolism)
  • Blotting, Western
  • Bromocriptine (pharmacology)
  • Cell Line
  • Dopamine Agonists (pharmacology)
  • Dose-Response Relationship, Drug
  • Excitatory Amino Acid Antagonists (pharmacology)
  • Excitatory Amino Acid Transporter 2 (metabolism)
  • Excitatory Amino Acids (antagonists & inhibitors)
  • Glutamic Acid (metabolism)
  • Humans
  • Mice
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: